University of Pennsylvania School of Medicine scientists say they've determined why cold sores caused by a herpes virus keep reappearing.
The study points to a small RNA molecule called a microRNA as the culprit that keeps the latent virus-infected cell alive.
A research team led by Microbiology Professor Nigel Fraser found herpes simplex virus-1, or HSV-1, the virus that causes cold sores and ocular keratitis, produces an miRNA molecule. That miRNA is encoded by the Latency-Associated Transcript gene in the viral genome and works through a process called RNA interference to prevent normal cell death or apoptosis. Thus, the latent viral infection is maintained for the lifetime of the individual because the latently infected cell does not die.
"Although miRNAs encoded by cellular genes are known to be an important mechanism for controlling gene expression, this is one of the first miRNA found to be encoded by a viral genome," said Fraser. "Our study helps show how HSV-1 can maintain a latent infection for the lifetime of an infected individual."
The finding, which might lead to a new way to fight the virus, is detailed in the journal Nature.
Copyright 2006 by United Press International
Related stories:
Researches identify herpesvirus proteins that target key cellular processes
A study published July 11th in the open-access journal
PLoS Pathogens suggests that herpesviruses use multiple strategies to manipulate important components of the host cell nuclear environment during infection. The study, conducted by researchers at the University of Toronto in collaboration with Affinium Pharmaceuticals Inc., provides novel insights into the potential functions of over 120 previously uncharacterized viral proteins.
Virus mimics human protein to hijack cell division machinery
Viruses are masters of deception, duping their host's cells into helping them grow and spread. A new study has found that human cytomegalovirus (HCMV) can mimic a common regulatory protein to hijack normal cell growth machinery, disrupting a cell's primary anti-cancer mechanism.
Researchers identify how herpes virus infects host cells
Virginia Commonwealth University researchers have uncovered new information about how the herpes simplex virus takes control of the host cell, setting the stage for the development of antiviral drugs that serve to fight herpes infections.
Specialized natural killer cells in human tonsils pack a punch
Tonsils are a source of sore throats and an excuse for ice cream. But they also provide an important protective service, their immune-cell-rich tissue acting as the body’s first defense against the germs about to be swallowed or inhaled. Researchers have known that tonsils are packed with B cells, which flag invaders for other cells to attack. But a new study by Rockefeller University scientists shows that tonsils also house a different, very specialized cell that helps protect against the Epstein Barr virus (EBV).
Scientists find a protein that inhibits Ebola from reaching out to infect neighboring cells
Scientists at the University of Pennsylvania School of Veterinary Medicine have identified a protein, ISG15, that inhibits the Ebola virus from budding, the process by which viruses escape from cells and spread to infect neighboring cells.
Gene therapy 'trains' immune system to destroy brain cancer cells and reverses behavioral deficits
A new gene therapy approach that attracts and “trains” immune system cells to destroy deadly brain cancer cells also provides long-term immunity, produces no significant adverse effects and -- in the process of destroying the tumor -- promotes the return of normal brain function and behavioral skills, according to a study conducted by researchers at Cedars-Sinai Medical Center’s Board of Governors Gene Therapeutics Research Institute.
Herpes medication does not reduce risk of HIV infection in individuals with HSV-2
An international clinical trial has found that acyclovir, a common medication for treating herpes simplex virus-2 (HSV-2), the most common cause of genital herpes, does not reduce the risk of HIV infection when taken by people infected with HSV-2. Multiple studies have shown that people with HSV-2 have a higher risk of acquiring HIV.
Scientists Develop Novel Vaccine Concept
Creating vaccines to protect people against viral diseases like AIDS, cervical cancer and infectious hepatitis is a delicate balancing act: If the immune system’s response to the vaccine is too strong, toxic side effects can kill the patient. If it’s not strong enough, the virus will spread faster than the immune system can kill it.